Erratum

Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39)

Laura Pizzi, A. Talati, E. Gemmen, N. V. Dahl, T. J. Bunz, P. K. Sand

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)534-535
Number of pages2
JournalPharmacoEconomics
Volume30
Issue number6
DOIs
StatePublished - May 21 2012

Fingerprint

Overactive Urinary Bladder
Pharmaceutical Economics
Workplace
Costs and Cost Analysis
oxybutynin

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

@article{0ec43f98929f4f9d9d8f09f6fa41f815,
title = "Erratum: Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39)",
author = "Laura Pizzi and A. Talati and E. Gemmen and Dahl, {N. V.} and Bunz, {T. J.} and Sand, {P. K.}",
year = "2012",
month = "5",
day = "21",
doi = "10.2165/11633660-000000000-00000",
language = "English (US)",
volume = "30",
pages = "534--535",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "6",

}

Erratum : Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39). / Pizzi, Laura; Talati, A.; Gemmen, E.; Dahl, N. V.; Bunz, T. J.; Sand, P. K.

In: PharmacoEconomics, Vol. 30, No. 6, 21.05.2012, p. 534-535.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Erratum

T2 - Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39)

AU - Pizzi, Laura

AU - Talati, A.

AU - Gemmen, E.

AU - Dahl, N. V.

AU - Bunz, T. J.

AU - Sand, P. K.

PY - 2012/5/21

Y1 - 2012/5/21

UR - http://www.scopus.com/inward/record.url?scp=84861027091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861027091&partnerID=8YFLogxK

U2 - 10.2165/11633660-000000000-00000

DO - 10.2165/11633660-000000000-00000

M3 - Comment/debate

VL - 30

SP - 534

EP - 535

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - 6

ER -